Pacing for neurally mediated syncope: Is placebo powerless?

Europace

Volumn 9, Issue 1, 2007, Pages 31-33

  Brignole, M ^a   Sutton, R ^b  

^a DEPARTMENT OF CARDIOLOGY   (Italy)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Electrocardiographic monitoring; Implantable loop recorder; Neurally mediated syncope; Pacemaker therapy; Syncope

Indexed keywords

PLACEBO;

ARTICLE; ARTIFICIAL HEART PACEMAKER; ASYSTOLE; BRADYCARDIA; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART PACING; HUMAN; PRIORITY JOURNAL; RANDOMIZATION; RECURRENCE RISK; RECURRENT DISEASE; SYNCOPE;

FOLLOW-UP STUDIES; HUMANS; PACEMAKER, ARTIFICIAL; PLACEBO EFFECT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SYNCOPE; TREATMENT OUTCOME;

EID: 33846473589     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul169     Document Type: Article

References (15)

1. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second vasovagal pacemaker study (VPS II). JAMA 2003;289:2224-9.
2. Raviele A, Giada F, Menozzi C, Speca G, Orazi S, Gasparini G et al. The vasovagal syncope and pacing trial (Synpace). A randomized placebo-controlled study of permanent pacing for treatment of recurrent vasovagal syncope. Eur Heart J 2004;25:1741-8.
3. Connolly SJ, Sheldon R, Roberts RS, Gent M. Vasovagal pacemaker study investigators. The North American vasovagal pacemaker study (VPS): A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20.
4. Sutton R, Brignole M, Menozzi C, Raviele A, Atboni P, Giani P et al. Dual-chamber pacing in treatment of neurally-mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multicentre randomized study. Circulation 2000;102:294-9.
5. Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Circulation 2001;104:52-57.
6. Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: A double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 1999;99:1452-7.
7. Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sanchez A et al. Lack of efficacy of atenolol for the prevention of neurally-mediated syncope in highly symptomatic population: A prospective double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001;37:554-7.
8. Sheldon R, Connolly S, Rose S, Klingenheben T, Krhan A, Morillo C et al. Prevention of syncope trial (POST). A randomised, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006;113:1164-70.
9. Sheldon R, Rose S, Koshman M. Comparison of patients with syncope of unknown cause having negative or positive tilt-table tests. Am J Cardiol 1997;80:581-5.
10. Natale A, Geiger MJ, Maglio C, Newby KH, Dhala A, Akhtar M et al. Recurrence of neurocardiogenic syncope without pharmacologic interventions Am J Cardiol 1996;77:1001-3.
11. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W et al. Early application of an implantable loop recorder allows a mechanism-based effective therapy in patients with recurrent suspected neurally-mediated syncope. Eur Heart J 2006;27:1085-92.
12. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Tognarini S, Mont L et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001;104:1261-7.
13. Hrobjartsson A, Gotzsche P. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment N Engl J Med 2001;344:1594-602.
14. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally-mediated syncope. Eur Heart J 2006;27:2232-9.
15. ISSUE 3: International Study on Syncope of Uncertain Etiology 3. Pacemaker therapy for patients with asystolic neurally-mediated syncope. Clinical Trials.gov 2006 Identifier: NCT 00359203.